Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c684df17c1e09127a3765f1138203f85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_249ec306bfb7048700ceab21f6f476a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d535e31d57314f23d3cb10f038ee994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7b7bd8c1fd4b2c79f0bba200da1bbc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0b5448de1f8530b7a18954b3117189c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
filingDate |
2001-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f9db33f63b7afa51757e96a6c976cfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe94c52743fed3bee0238f413dc59fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cff84cc290ecaac25a86357289350880 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cadce8c362e71b6fa31b8766a96dfb7 |
publicationDate |
2002-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0229074-A2 |
titleOfInvention |
Genetic immunisation against cervical carcinoma |
abstract |
The invention provides a method for the treatment or prevention of cervical cancer comprising providing an individual with a medicament comprising an alphavirus vector system(s) and/or a cell(s) comprising nucleic acid derived from human papilloma virus (HPV) for the preparation of a medicament wherein said medicament is a vaccine for the treatment of cervical cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7198792-B2 |
priorityDate |
2000-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |